Market Value185,688,000
Total Holdings72
File Date2018-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
NLTX / Neoleukin Therapeutics, Inc.
YMTX / Yumanity Therapeutics Inc
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
FSTX / F-star Therapeutics Inc
FOMX / Foamix Pharmaceuticals Ltd.
ISEE / IVERIC bio Inc
EXAC / Exactech, Inc.
NDRM / NeuroDerm Ltd.
SLS / SELLAS Life Sciences Group, Inc.
NXTM / NxStage Medical, Inc.
QURE / uniQure N.V.
74365AAB7 / Protalix BioTherapeutics, Inc. Bonds 4.5% 9/15/18
24983LAA2 / Dermira Inc Bond
US750469AA69 / Radius Health, Inc. Bond
ZGNX / Zogenix Inc
AGTC / Applied Genetic Technologies Corp
ADMP / Adamis Pharmaceuticals Corp
IL0011177958 / Intec Pharma Ltd
RDUS / Radius Recycling, Inc.
JNJ / Johnson & Johnson
NERV / Minerva Neurosciences, Inc.
ATNM / Actinium Pharmaceuticals, Inc.
ALDR / Alder BioPharmaceuticals, Inc.
252131AE7 / Dexcom Inc Bond
SCPH / scPharmaceuticals Inc.
LOXO / Loxo Oncology, Inc.
VBIV / VBI Vaccines Inc.
IMDZ / Immune Design Corp.
45780VAB8 / Inotek Pharmaceuticals Corporation Bonds 5.75% 8/1/2021
LPTX / Leap Therapeutics, Inc.
US46333XAD03 / Ironwood Pharmaceuticals, Inc. DBCV 2.250% 6/1
US64052L1061 / Neos Therapeutics, Inc.
CMTA / Clementia Pharmaceuticals Inc.
CTMX / CytomX Therapeutics, Inc.
45784PAG6 / Insulet Corp Bond
US00448Q2012 / Achillion Pharmaceuticals, Inc.
DERM / Journey Medical Corporation
BLCM / Bellicum Pharmaceuticals, Inc.
OBSV / ObsEva SA.
VSCI /
SRRA / Sierra Oncology Inc
NTUS / Natus Medical Inc
ADXS / Ayala Pharmaceuticals, Inc.
ARQL / ArQule, Inc.
US0906721065 / BioTelemetry, Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
US55027E1029 / Luminex Corporation
KDMN / Kadmon Holdings Inc
/ Immunomedics, Inc.
MGNX / MacroGenics, Inc.
SAGE / Sage Therapeutics, Inc.
CASC / Cascadian Therapeutics, Inc.
BGNE / BeiGene, Ltd. - Depositary Receipt (Common Stock)
AERI / Aerie Pharmaceuticals Inc
PDSB / PDS Biotechnology Corporation
AGLE / Aeglea BioTherapeutics Inc
VYGR / Voyager Therapeutics, Inc.
NBIX / Neurocrine Biosciences, Inc.
AKBA / Akebia Therapeutics, Inc.
SCYX / SCYNEXIS, Inc.
ARDX / Ardelyx, Inc.
STXS / Stereotaxis, Inc.
BLUE / bluebird bio, Inc.
CARA / Cara Therapeutics, Inc.
RIGL / Rigel Pharmaceuticals, Inc.
CBAY / CymaBay Therapeutics, Inc.
VIRX / Viracta Therapeutics, Inc.
CDTX / Cidara Therapeutics, Inc.
RDHL / RedHill Biopharma Ltd. - Depositary Receipt (Common Stock)
ATRC / AtriCure, Inc.
KURA / Kura Oncology, Inc.
MASI / Masimo Corporation
SPRO / Spero Therapeutics, Inc.
DCPH / Deciphera Pharmaceuticals, Inc.
PRQR / ProQR Therapeutics N.V.
BPMC / Blueprint Medicines Corporation
PODD / Insulet Corporation
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
LCTX / Lineage Cell Therapeutics, Inc.
IBB / iShares Trust - iShares Biotechnology ETF
BCRX / BioCryst Pharmaceuticals, Inc.
DXCM / DexCom, Inc.
XENE / Xenon Pharmaceuticals Inc.